Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Allergen describes compounds with retinoid-like activity

Sep. 6, 1996

Interferon gamma-1b enters pivotal trials for atopic dermatitis

Sep. 6, 1996

ProCyte cleared for clinical trials with wound-healing product

Sep. 6, 1996

ProCyte issued patents covering hair loss applications

Sep. 6, 1996

Ornithine decarboxylase inhibitors for dermatology

Sep. 6, 1996

Xoma/Genentech to commence clinical trials with humanized monoclonal antibody

Sep. 6, 1996

ADCON-L and ADCON-T/N research demonstrates efficacy

Aug. 30, 1996

Treatment for keratinization disorders described by Janssen

Aug. 30, 1996

Sepracoat given European Approval of Conformity Certificate

Aug. 30, 1996

Repel proved effective in preclinical studies

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...